✦ LIBER ✦

1917 PROGNOSITIC SIGNIFICANCE OF C-REACTIVE PROTEIN IN INTERMEDIATE-RISK JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH MOLECULAR TARGETED THERAPY

✍ Scribed by Teishima, Jun; Hayashi, Tetsutaro; Seno, Yasuyuki; Ikeda, Kenichiro; Oka, Kiyotaka; Nagamatsu, Hirotaka; Hieda, Keisuke; Shoji, Koichi; Miyamoto, Katsutoshi; Inoue, Shogo; Kobayashi, Kanao; Ohara, Shinya; Kajiwara, Mitsuru; Matsubara, Akio

Book ID: 122988326
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 50 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.2336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in peripheral blood immune cells

Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy

✍ Kobayashi, Minoru; Kubo, Taro; Komatsu, Kenji; Fujisaki, Akira; Terauchi, Fumihi 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 494 KB

C-REACTIVE PROTEIN: A BIOMARKER OF SURVI

C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

✍ CASAMASSIMA, ADDOLORATA; PICCIARIELLO, MARGHERITA; QUARANTA, MICHELE; BERARDINO, 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 75 KB

RE: C-REACTIVE PROTEIN: A BIOMARKER OF S

RE: C-REACTIVE PROTEIN: A BIOMARKER OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUBCUTANEOUS INTERLEUKIN-2 BASED IMMUNOTHERAPY

✍ Ramsey, Sara; Aitchison, Michael 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

Improvement of prognosis in patients wit

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice

✍ Tomomi Kamba, Toshinari Yamasaki, Satoshi Teramukai, Noboru Shibasaki, Ryuichiro 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 434 KB

1786 C-REACTIVE PROTEIN AS A MARKER OF T

1786 C-REACTIVE PROTEIN AS A MARKER OF TREATMENT RESPONSE AND PREDICTOR OF PROGNOSIS IN CHINESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH SUNITINIB

✍ shi, guohai 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB

Association of percentage of tumour burd

Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Juan Barbastefano; Jorge A. Garcia; Paul Elson; Laura S. Wood; Brian R. Lane; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB